A cosmetic regulatory authority that would like to attend the annual meeting as an observer, may make a request to Health Canada (HC), which is the current Chair of the International Cooperation on Cosmetics Regulation (ICCR).

For participation in the ICCR-19 Annual Meeting, which will be held July 8-10, 2025, in Ottawa, Canada, a request to attend should be sent to the Chair of ICCR-19 by April 8, 2025.

Please note that space is limited. The letter can be sent electronically to:

Nibal Saikali
(she | elle)
ICCR-19 Chair
Health Canada / Santé Canada
nibal.saikali@hc-sc.gc.ca

 

1. Annual Meeting: a regulator must request participation in a letter to the current ICCR Chair no later than 3 months before the date of the ICCR Annual Meeting, including information about Industry Trade Association (ITA) participation. The number of participants allowed is described in the ICCR Standard Operating Procedures. If necessary, the letter must include the extra participants request with the respective justification.

2. Quarterly Regulator-Industry Teleconferences: a regulator must request or renew its participation to the current ICCR Chair no later than 1 month after the ICCR Annual Meeting. The regulator that attended the last ICCR Annual Meeting or participated in the previous cycle can renew its participation by e-mail while other regulators must do it by letter. The absence of an observer regulator in two consecutive teleconferences without justification will determine the exclusion of the observer regulator and the respective ITA from the ICCR activities during the current cycle.

3. ICCR Working Group: an ICCR observer regulator who requested participation in the quarterly regulator-industry teleconferences and wishes to participate in an ICCR Working Group must request it by e-mail to the current ICCR Chair no later than 1 month after the ICCR Annual Meeting.

• pdfRequirements for ICCR Observers

At the 5th ICCR Annual Meeting (July 2011), the ICCR Steering Committee considered expanding the ICCR membership to include other countries expressing an interest.  Since 2012, other cosmetic regulatory authorities have been able to participate as ICCR observers.

Brazil was accepted as a member of the ICCR Steering Committee following the 8th ICCR Annual Meeting (July 2014).

Taiwan Food and Drug Administration (TFDA) - Chinese Taipei and Ministry of Food and Drug Safety (MFDS) - Republic of Korea were accepted as members of the ICCR Steering Committee following the 14th ICCR Annual Meeting (December 2020).

 

The Ministry of Health of Israel (MOH) was accepted as member of the ICCR Steering Committee following the 16th ICCR Annual Meeting (June 2022).

The inclusion of other members of the ICCR and their appropriate status is decided by consensus by the ICCR Steering Committee.

• pdfRequirements to become Steering Committee Member
• pdfRequirements for Chairing an ICCR Cycle

A stakeholder session is generally organized as part of the ICCR annual meeting. Interested parties may contact the current ICCR Chair for further information.